$3.12
-0.04-1.27%
At Close: -
$3.13
0.00870.28%
After Hours: 7:28 PM EDT
15 minutes delayed
Arbutus Biopharma
ABUSNASDAQ
Arbutus Biopharma (NASDAQ:ABUS) Stock, Earnings Estimates, EPS, And Revenue
Arbutus Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 1
EPS Estimate
$-0.100
Quarterly Revenue Estimate
$1.8M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$13M
Analyze the earnings history of Arbutus Biopharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma | -$0.10 | -$0.10 | — | — | $4.65M | $1.75M | — | — | 08/01/2024 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.10 | -$0.11 | -$0.10 | 9.09% | $6.69M | $2.15M | $1.53M | -28.74% | 05/02/2024 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.14 | -$0.12 | -$0.12 | 0.00% | $6.25M | $4.79M | $2.15M | -55.22% | 02/29/2024 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.12 | -$0.11 | -$0.12 | -9.09% | $5.95M | $4.75M | $4.66M | -1.94% | 11/07/2023 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.10 | -$0.12 | -$0.10 | 16.67% | $14.24M | $5.02M | $4.65M | -7.35% | 08/03/2023 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.11 | -$0.14 | -$0.10 | 28.57% | $12.58M | $6.03M | $6.69M | 10.90% | 05/04/2023 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.15 | -$0.13 | -$0.14 | -7.69% | $3.21M | $6.17M | $6.25M | 1.22% | 03/02/2023 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.24 | -$0.13 | -$0.12 | 7.69% | $3.34M | $9.37M | $5.95M | -36.48% | 11/09/2022 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.23 | -$0.13 | -$0.10 | 23.08% | $2.33M | $6.77M | $14.24M | 110.35% | 08/04/2022 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.21 | -$0.16 | -$0.11 | 31.25% | $2.11M | $4.37M | $12.58M | 187.89% | 05/05/2022 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.23 | -$0.19 | -$0.15 | 21.05% | $2.39M | $2.87M | $3.21M | 11.71% | 03/03/2022 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.27 | -$0.24 | -$0.24 | 0.00% | $1.52M | $2.38M | $3.34M | 40.34% | 11/04/2021 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.25 | -$0.22 | -$0.23 | -4.55% | $1.51M | $2.12M | $2.33M | 9.86% | 08/05/2021 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.25 | -$0.23 | -$0.21 | 8.70% | $1.49M | $3.31M | $2.11M | -36.16% | 05/05/2021 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.46 | -$0.22 | -$0.23 | -4.55% | $1.62M | $1.96M | $2.39M | 21.73% | 03/04/2021 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.73 | -$0.22 | -$0.27 | -22.73% | $3.10M | $1.66M | $1.52M | -8.25% | 11/05/2020 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.46 | -$0.24 | -$0.25 | -4.17% | $700.00K | $1.74M | $1.51M | -12.99% | 08/07/2020 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.47 | -$0.39 | -$0.25 | 35.90% | $700.00K | $220.00K | $1.49M | 577.73% | 05/11/2020 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.37 | -$0.39 | -$0.46 | -17.95% | $1.60M | $220.00K | $1.62M | 635.45% | 03/05/2020 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.30 | — | -$0.73 | — | $1.60M | — | $3.10M | — | 11/06/2019 | Get Alert |
| ABUS | Arbutus Biopharma | -$0.44 | -$0.39 | -$0.46 | -17.95% | $1.20M | $220.00K | $700.00K | 218.18% | 08/05/2019 | Get Alert |
Arbutus Biopharma (ABUS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $-0.10 | $-0.11 | 9.09 % |
| Dec 2023 | 2024-02-29 | $-0.12 | $-0.12 | 0.00 % |
| Sep 2023 | 2023-11-07 | $-0.12 | $-0.11 | -9.09 % |
| Jun 2023 | 2023-08-03 | $-0.10 | $-0.12 | 16.7 % |
Arbutus Biopharma (ABUS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $1.53M | $2.15M | -28.7 % |
| Dec 2023 | 2024-02-29 | $2.15M | $4.79M | -55.2 % |
| Sep 2023 | 2023-11-07 | $4.66M | $4.75M | -1.94 % |
| Jun 2023 | 2023-08-03 | $4.65M | $5.02M | -7.35 % |
FAQ
When is Arbutus Biopharma (NASDAQ:ABUS) reporting earnings?
Arbutus Biopharma (ABUS) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
What were the latest earnings per share (EPS) for Arbutus Biopharma (NASDAQ:ABUS)?
The Actual EPS was $-0.10, which beat the estimate of $-0.11.
What were Arbutus Biopharma’s (NASDAQ:ABUS) revenues?
The Actual Revenue was $1.5M, which missed the estimate of $2.1M.
Browse earnings estimates, EPS, and revenue on all stocks.